# Intranasal Oxytocin for the Treatment of Autism Spectrum Disorders

> **NCT01337687** · NA · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 19 (actual)

## Conditions studied

- Autism Spectrum Disorders

## Interventions

- **DRUG:** Intranasal Oxytocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01337687
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2020-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01337687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01337687, "Intranasal Oxytocin for the Treatment of Autism Spectrum Disorders". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01337687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*